Facebook
Twitter
LinkedIn
Forward
A Message from the AAAAI
As the coronavirus disease 2019 (COVID-19) spreads across the globe, we recognize the importance of our roles as healthcare providers, particularly to patients known for asthma, other allergic conditions, or immune deficiencies who may be at a higher risk of experiencing severe symptoms from the disease. The same way that you are committed to your patients, practices, and communities, we at the AAAAI remain committed to providing you with resources that will help you navigate this difficult period.
If you have any specific questions regarding the treatment of patients or management of your practice, please contact us at practicematters@aaaai.org.
For the latest information on COVID-19 and our resources, read the messages sent to members from the AAAAI COVID-19 Response Task Force.
COVID-19 Vaccines, Monoclonal Antibodies and Other Treatments
New developments related to vaccines and treatments for COVID-19 are being released rapidly. Check this page regularly for the latest updates.
Summaries of Key Topics
- This article in JACI: In Practice regarding the evaluation of a possible vaccine allergic patient will likely be of interest to allergist/immunologists.
Vaccine Distribution and Administration
Monoclonal Antibodies and Other Treatments
Virus Variants and Vaccine Information
Guidance and Resources from the AAAAI
Ask the AAAAI Questions asked by members and answered by the COVID-19 Task Force.
Submit questions to practicematters@aaaai.org
Read this comprehensive resource document on COVID 19 vaccines from the AAAAI’s Advocacy partner, Hart Health Strategies.
External Resources
- CDC: Vaccines
- FDA: COVID-19 Vaccines
- NIH: COVID-19 Treatment Guidelines: What's New
- COVID Collaborative hosted COVID-19 Action in the Biden Era: A Fireside Chat with Dr. Fauci on February 9. Watch the recording here.
Resources for A/I Clinicians
 |  |  |  |
 |  |  |  |
AAAAI Original Resources
An Update on COVID-19 for the Practicing Allergist/immunologist (Updated 3/1/21)
Caring for Pregnant Patients with Asthma during the COVID-19 Pandemic (Updated 12/21/20)
Coronavirus Disease 2019 (COVID-19) with a Focus on Older Adults: A Guide for Allergist/Immunologists and Patients (Updated 9/23/20)
The Relationship Between COVID-19 and Asthma: A Summary of the Research to Date (9/4/20)
Food Allergy and Anaphylaxis in School during COVID-19 (9/20)
School Attendance, Asthma and COVID-19 (8/20)
Do Your Part to Slow the Spread of COVID-19: Wear a Face Covering or Mask (Updated 7/24/20)
Available en español
Suggestions or Considerations for Resuming Practice drafted by the COVID-19 Response Task Force (5/5/20)
COVID-19 Articles in AAAAI Journals
The AAAAI journals are offering free access to the articles they publish related to COVID-19. Visit their COVID-19 pages by clicking the logos below.
Visit the In Practice Virtual Journal Club page for a list of upcoming and previous journal clubs.
Ask the AAAAI about COVID-19
The AAAAI invites you to send your COVID-19 questions to practicematters@aaaai.org. Questions and responses that might be helpful for a wider audience are provided in the links below.
Advocacy Updates and Outreach Tools
The AAAAI is committed to advocating for our members and your patients, and maximizing our effectiveness requires broad engagement: AAAAI leadership, our Advocacy Committee and other volunteer leaders, our team of government relations experts at Hart Health Services, and our professional staff; but most importantly – our members. Member engagement in advocacy outreach is important at the national, state, and local level. Visit our special COVID19-focused advocacy page frequently for the latest on related national news: AAAAI COVID-19 Advocacy
Engagement on the national level is just one part of impactful outreach. We are pleased to provide you with resources to use in your own community. There’s a template media alert you can use to describe the unique perspective that you as an allergist can offer, and a template press release on what patients need to know about asthma and COVID-19. There’s a set of talking points to get you started, but of course your discussion of what’s happening in your own community is the most influential. Modify the templates for your own use in your community. Please note that use of these materials is for your own outreach and not on behalf of the AAAAI, but please let us know how it goes and send your clips or questions to advocacy@aaaai.org.
COVID-19 and Asthma Template Press Release.docx
COVID-19 Talking Points for Allergists to Use with Media.docx